Mercer Global Advisors
MAIA icon

Mercer Global Advisors’s MAIA Biotechnology MAIA Stock Holding History

Mercer Global Advisors’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$655 Buy
+455
New +$604 ﹤0.01% 5793

Other funds holding MAIA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mercer Global Advisors's MAIA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 455 shares worth $655. The stake represents ﹤0.01% of the portfolio and ranks #5793 among its holdings.

25 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Mercer Global Advisors held 455 shares of MAIA Biotechnology worth $655 as of Q2 2026.
  • MAIA Biotechnology was a new Mercer Global Advisors position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5793 holding.
  • 25 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.